Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
Onat Kadioglu, Mohamed E.M. Saeed, Henry Johannes Greten, et al.
Computers in Biology and Medicine (2021) Vol. 133, pp. 104359-104359
Open Access | Times Cited: 160

Showing 26-50 of 160 citing articles:

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
Ahmad Alzamami, Norah A. Alturki, Youssef Saeed Alghamdi, et al.
Medicina (2022) Vol. 58, Iss. 4, pp. 515-515
Open Access | Times Cited: 31
A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 699-721
Open Access | Times Cited: 30
Understanding basic principles of Artificial Intelligence: a practical guide for intensivists.
Valentina Bellini, Marco Cascella, Francesco Cutugno, et al.
PubMed (2022) Vol. 93, Iss. 5, pp. e2022297-e2022297
Closed Access | Times Cited: 30
An ensemble computational model for prediction of clathrin protein by coupling machine learning with discrete cosine transform
Majdi Khalid, Farman Ali, Wajdi Alghamdi, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-9
Closed Access | Times Cited: 5
A virtual screening framework based on the binding site selectivity for small molecule drug discovery
Xinhao Che, Qilei Liu, Fang Yu, et al.
Computers & Chemical Engineering (2024) Vol. 184, pp. 108626-108626
Closed Access | Times Cited: 4
Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis
Mahesha Nand, Priyanka Maiti, Tushar Joshi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
A comprehensive review on potential therapeutics interventions for COVID-19
Heerak Chugh, Amardeep Awasthi, Yashi Agarwal, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173741-173741
Open Access | Times Cited: 41
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
Yash Gupta, Dawid Maciorowski, Samantha E. Zak, et al.
Methods (2021) Vol. 195, pp. 57-71
Open Access | Times Cited: 35
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro
Karen Anbro Gammeltoft, Yuyong Zhou, Carlos R. Duarte Hernandez, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 9
Open Access | Times Cited: 35
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors
Mario Milani, Manuela Donalisio, Rafaela Milan Bonotto, et al.
Antiviral Research (2021) Vol. 189, pp. 105055-105055
Open Access | Times Cited: 34
A metabolic modeling approach reveals promising therapeutic targets and antiviral drugs to combat COVID-19
Fernando Santos‐Beneit, Vytautas Raškevičius, Vytenis Arvydas Skeberdis, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19
Yi Cong, Toshinori Endo
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 7, pp. 361-371
Open Access | Times Cited: 25
Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine (NSL-CG) against SARS CoV-2: a virtual screening and molecular dynamics simulation study
Youssef Saeed Alghamdi, Mutaib M. Mashraqi, Ahmad Alzamami, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6633-6642
Closed Access | Times Cited: 25
Emerging quinoline‐ and quinolone‐based antibiotics in the light of epidemics
Paranjeet Kaur, A Anuradha, Avik Chandra, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 6, pp. 765-785
Closed Access | Times Cited: 24
Hepatitis C Virus Detection Model by Using Random Forest, Logistic-Regression and ABC Algorithm
Tzuu‐Hseng S. Li, Huan-Jung Chiu, Ping‐Huan Kuo
IEEE Access (2022) Vol. 10, pp. 91045-91058
Open Access | Times Cited: 21
Innovative applications of artificial intelligence in zoonotic disease management
Wenqiang Guo, Chenrui Lv, Meng Guo, et al.
Science in One Health (2023) Vol. 2, pp. 100045-100045
Open Access | Times Cited: 13
Current state and prospects of artificial intelligence in allergy
Merlijn van Breugel, Rudolf S.N. Fehrmann, Marnix Bügel, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2623-2643
Open Access | Times Cited: 11
Combating COVID-19 Crisis using Artificial Intelligence (AI) Based Approach: Systematic Review
Kavya Singh, Navjeet Kaur, Ashish A. Prabhu
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 8, pp. 737-753
Closed Access | Times Cited: 3
Battling COVID-19 using machine learning: A review
Krishnaraj Chadaga, Srikanth Prabhu, Vivekananda Bhat K, et al.
Cogent Engineering (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 27
The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates
Gajendra Kumar Azad
Heliyon (2021) Vol. 7, Iss. 2, pp. e06167-e06167
Open Access | Times Cited: 26
Chemical biology and medicinal chemistry of RNA methyltransferases
Tim R. Fischer, Laurenz Meidner, Marvin Schwickert, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 8, pp. 4216-4245
Open Access | Times Cited: 18
D3AI-CoV: a deep learning platform for predicting drug targets and for virtual screening against COVID-19
Yanqing Yang, Deshan Zhou, Xinben Zhang, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 18
Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing
Md. Ariful Islam, Md. Kaderi Kibria, Md. Bayazid Hossen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications
Biswajit Naik, Venkata Satish Kumar Mattaparthi, Nidhi Gupta, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 19, pp. 9543-9567
Open Access | Times Cited: 25
Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
Mahmudul Hasan, Md. Sorwer Alam Parvez, Kazi Faizul Azim, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111742-111742
Open Access | Times Cited: 23

Scroll to top